Stockreport

TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update

TriSalus Life Sciences, Inc.  (TLSI) 
PDF Revenues of $8.3 Million in Q4 and $29.4 Million for Full-Year 2024, Representing Growth of 44% And 59%, Respectively, Versus the Prior Year PeriodsGross Margin of 85% a [Read more]